Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

1.0K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.0K
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

204
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
204

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic value of EUS-guided tissue acquisition in suspected autoimmune pancreatitis: A 15-year single-center retrospective study.

Endoscopic ultrasound·2026
Same author

Impact of Cirrhosis Etiology and Intensive Care Accessibility on Upper Gastrointestinal Bleeding: A Prospective Observational Study.

Canadian journal of gastroenterology & hepatology·2026
Same author

Integrated physiological, transcriptomic and widely targeted metabolomic analyses reveal the underlying mechanism of cold stress response in the panicle apical abortion line J876 derived from Oryza rufipogon.

Plant physiology and biochemistry : PPB·2026
Same author

Effect of terlipressin on renal outcomes in patients with liver cirrhosis and ascites: a retrospective multicenter study.

Expert review of clinical pharmacology·2026
Same author

Plasma Extracellular Vesicle Proteomics Reflects Graded Inflammation within the COCA Classification Framework for Chronic Pancreatitis.

Pancreas·2026
Same author

Effect of <i>Helicobacter pylori</i> infection on the risk of inflammatory bowel disease: an umbrella review and second-order meta-analysis.

Therapeutic advances in gastroenterology·2026

Related Experiment Video

Updated: Sep 15, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.5K

Interferon in Liver Diseases: Recent Advances.

Yuting Gao1, Yuhang Yin1,2, Pengpeng Xie1,3

  • 1Department of Gastroenterology, General Hospital of Northern Theater Command (Teaching Hospital of Dalian Medical University), Shenyang, China.

Advances in Therapy
|July 17, 2025
PubMed
Summary

Interferons (IFNs) are crucial cytokines impacting liver health. This review explores how IFN signaling pathways influence liver diseases, offering new therapeutic strategies for better patient outcomes.

Keywords:
Alcohol-associated liver diseaseHepatocellular carcinomaInterferonLiver fibrosisNon-alcoholic fatty liver diseaseViral hepatitis

More Related Videos

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-&#945;
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.1K
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

20.9K

Related Experiment Videos

Last Updated: Sep 15, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.5K
Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-&#945;
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.1K
Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

20.9K

Area of Science:

  • Immunology
  • Hepatology
  • Molecular Biology

Background:

  • Interferons (IFNs) are key cytokines involved in antiviral defense, immune regulation, and antitumor activity.
  • Distinct IFN types (I, II, III) exhibit diverse biological effects.
  • IFN production is triggered by pattern recognition receptor signaling, activating crucial downstream pathways.

Purpose of the Study:

  • To delineate the mechanistic roles of IFN-associated signaling in various liver diseases.
  • To elucidate IFN-mediated regulatory networks in viral defense, metabolic dysregulation, immune responses, and inflammation.
  • To provide novel therapeutic directions for managing liver diseases through context-specific IFN dynamics.

Main Methods:

  • Comprehensive literature review of IFN signaling pathways in liver disease.
  • Analysis of mechanistic roles in viral hepatitis, NAFLD, ALD, fibrosis, and HCC.
  • Integration of insights into IFN-mediated regulatory networks.

Main Results:

  • IFN signaling pathways critically influence the pathogenesis, progression, and prognosis of liver diseases.
  • IFN dynamics are implicated in viral defense, metabolic dysregulation, immune responses, and inflammation.
  • Understanding context-specific IFN dynamics is essential for effective therapeutic strategies.

Conclusions:

  • IFN signaling pathways represent a critical nexus in liver disease pathogenesis and progression.
  • Targeting IFN dynamics offers promising avenues for personalized therapeutic approaches in liver disease management.
  • Further research into context-specific IFN roles can improve clinical outcomes and address unmet needs.